Adjuvant Chemotherapy of Testicular Carcinoma: Need for Evaluation of Curative Strategies

  • F. M. Muggia
  • E. M. Jacobs
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 68)

Abstract

Newer regimens including cis-diamminedichloroplatinum (DDP) have shown a striking therapeutic efficacy against advanced testicular cancer [22]. The impact of such chemotherapy on our overall approach to this disease will be described. Preceding the description of current trials, a review of staging concepts and the prognostic implications of histology and stage is essential to understanding the concepts underlying current strategies.

Keywords

Lymphoma Oncol Mannitol Vincristine Teratoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    American Joint Committee for Cancer Staging and End Results Reporting. 1977.Google Scholar
  2. 2.
    Anderson, T., Waiden, T., Javadpour, N., Anderson, T., Glatstein, E.: Recent advances in diagnosis and therapy of testicular germ cell neoplasms. Ann. Intern. Med. (in press) (1978).Google Scholar
  3. 3.
    Boden, G. L., Gibb, R.: Radiotherapy and testicular neoplasms. Lancet 1951 II, 1195.Google Scholar
  4. 4.
    Carter, S. K., Wasserman, T. H.: The chemotherapy of urologic cancer. Cancer 36, 729–749 (1975).PubMedCrossRefGoogle Scholar
  5. 5.
    Chary, K., Higby, D., Henderson, E., Swinerton, K.: Phase I study of high dose cis-diamminedichloroplatinum(II) with forced diuresis. Cancer Treat. Rep. 61, 367–370 (1977).PubMedGoogle Scholar
  6. 6.
    Cheng, E., Cvitkovic, E., Wittes, R., Golbey, R.: Germ cel tumors (II): VAB II in metastatic testicular cancer. Cancer (in press) (1978).Google Scholar
  7. 7.
    Collins, D. H., Pugh, R. C. B.: Classification and frequency of testicular tumors. Br. J. Urol. 36, [Suppl 1], 1, (1964).Google Scholar
  8. 8.
    Corder, M. P., Maguire, L. C., Witte, D. L., Panther, S. K., Lovett, J. M., Dietz, B. J.: Weekly outpatient cis-platinum(II) diamminedichloride (CPDD) and diuresis with dose-limiting myelosuppression. Proc. Am. Assoc. Cancer Res./Proc. Am. Soc. Clin. Oncol. 18, 344 (1977).Google Scholar
  9. 9.
    Cvitkovic, E., Hayes, D., Golbey, R.: Primary combination chemotherapy (VAB III) for metastatic or unresectable germ cell tumors. Proc. Am. Assoc. Cancer Res. 17, 296 (1976) (Abs.).Google Scholar
  10. 10.
    Dixon, F., Moore, R.: Tumors of the male sex organs. In: Atlas of tumor pathology. Section 8, Part 31b and 32, pp. 48-127. Washington D. C.: Armed Forces Institute of Pathology.Google Scholar
  11. 11.
    Einhorn, L. H., Donohue, J. P.: Cis-diammine-dichloroplatinum, vinblastine, and bleomycin combination chemotherapy in dissemminated testicular cancer. Ann. Intern. Med. 87, 293–298 (1977).PubMedGoogle Scholar
  12. 12.
    Hayes, D. M., Cvitkovic, E., Golbey, R. B., Scheiner, E., Helson, L., Krakoff, I. H.: High dose cis-platinum diammine dichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39, 1372–1381 (1977).PubMedCrossRefGoogle Scholar
  13. 13.
    Higby, D. J., Wallace, H. J., Albert, D., Holland, J. F.: Diamminodichloroplatinum in the chemotherapy of testicular tumors. J. Urol. 112, 100–104 (1974).PubMedGoogle Scholar
  14. 14.
    Hussey, D. H., Luk, K. H., Johnson, D. E.: The role of radiation therapy in the treatment of germinal cell tumors of the testis other than pure seminoma. Radiology 123, 175–180 (1977).PubMedGoogle Scholar
  15. 15.
    Javadpour, N., Bergman, S.: Recent advances in testicular cancer. Curr. Probl. Surg. 25, 1–64 (1978).CrossRefGoogle Scholar
  16. 16.
    Lynch, D. F., McCord, L., Nicholson, T., Richie, J., Sargents, C.: Sandwich therapy in testis tumor: current experience. J. Urol. 119, 612–613 (1977).Google Scholar
  17. 17.
    Maier, J. G., VanBuskirk, K. E.: Treatment of testicular germ cell malignancies. JAMA 213, 97–98 (1970).PubMedCrossRefGoogle Scholar
  18. 18.
    Maier, J. G., Mittemeyer, B. T.: Carcinoma of the testis. Cancer 39, 981–986 (1977).PubMedCrossRefGoogle Scholar
  19. 19.
    Merrin, C.: A new method to prevent toxicity with high doses of cisdiammine platinum (therapeutic efficacy in previously treated widespread and recurrent testicular tumors). Proc. Am. Assoc. Cancer Res./Proc. Am. Soc. Clin. Oncol. 17, 243 (1976).Google Scholar
  20. 20.
    Merrin, C.: Multimodal treatment of advanced testicular tumor with cis-diammine dichloroplatinum (CPDD), bleomycin (BLEO), vinblastine (VLB), vincristine (VCR) and actinomycin D. Proc. Am. Assoc. Cancer Res. 18, 298 (1977).Google Scholar
  21. 21.
    Mostofi, F.: Testicular tumors: epidemiologic, etiologic, and pathologic features. Cancer 32, 1186–1201 (1973).PubMedCrossRefGoogle Scholar
  22. 22.
    Muggia, F. M., Jacobs, E. M.: Chemotherapy of testicular cancer: Impact on curability. Princess Takamatsu Symposium (in press) (1978).Google Scholar
  23. 23.
    Nitschke, R., Starling, K., Land, V., Komp, D.: Cis-platinum (PDD) in childhood malignancies. Proc. Am. Assoc. Cancer Res. 17, 310 (1976).Google Scholar
  24. 24.
    Osieka, R., Bruntsch, U., Gallmeier, W., Seeber, S., Schmidt, C.: Cis-diamminodichloro-platin in der Behandlung therapieresistenter maligner Hodenteratome. Dtsch. Med. Wochenschr. 101, 191–195 (1976).PubMedCrossRefGoogle Scholar
  25. 25.
    Rossof, A. H., Talley, R. W., Stephens, R. L.: Phase II evaluation of single high-dose cis-diamminedichloroplatinum in gynecologic and genitourinary neoplasia. Proc. Am. Assoc. Cancer Res. 18, 97 (1977).Google Scholar
  26. 26.
    Samuels, M., Lancotti, V., Holoye, P., Howe, G.: Stage III testicular cancer: Complete response by substage to velban plus continuous bleomycin infusion (VB-3). Proc. Am. Assoc. Cancer Res. 18, 146 (1977).Google Scholar
  27. 27.
    Staubitz, W. J., Early, R., Magoss, I., Murphy, G.: Surgical management of testis tumor. J. Urol. 111, 205 (1974).PubMedGoogle Scholar
  28. 28.
    Tyrell, C., Peckham, M.: The response of lymph node metastases of testicular teratom to radiation therapy. Br. J. Urol. 48, 363–370 (1976).CrossRefGoogle Scholar
  29. 29.
    Union Internationale Contre le Cancer: TNM classification of malignant tumors, 2nd ed. Geneva, 1974.Google Scholar
  30. 30.
    Vugrin, D., Cvitkovic, E., Whitmore, W., Golbey, R.: Prophylactic chemotherapy of testicular germ cell carcinomas (non-seminomas) Stage II following orchiectomy and retroperitoneal dissection. Proc. Am. Assoc. Cancer Res. 19, 352 (1978).Google Scholar
  31. 31.
    Wittes, R. E., Yagoda, A., Silvay, O., Magill, G., Whitmore, W., Krakoff, I., Golbey, R.: Chemotherapy of germ cell tumors of the testis. I. Induction of remissions with vinblastine, actinomycin D, and bleomycin. Cancer 37, 637–645 (1976).PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • F. M. Muggia
  • E. M. Jacobs

There are no affiliations available

Personalised recommendations